124 related articles for article (PubMed ID: 6197332)
1. Effects of proglumide on pancreatic acinar cell function.
Williams JA; Bailey A; Steigerwalt RW
Digestion; 1983; 27(4):227-33. PubMed ID: 6197332
[TBL] [Abstract][Full Text] [Related]
2. Proglumide (gastrin and cholecystokinin receptor antagonist) inhibits insulin secretion in vitro.
Verspohl EJ; Wunderle G; Ammon HP; Williams JA; Goldfine ID
Naunyn Schmiedebergs Arch Pharmacol; 1986 Mar; 332(3):284-7. PubMed ID: 3012373
[TBL] [Abstract][Full Text] [Related]
3. New proglumide-analogue CCK receptor antagonists: very potent and selective for peripheral tissues.
Niederau C; Niederau M; Williams JA; Grendell JH
Am J Physiol; 1986 Jun; 250(6 Pt 1):G856-60. PubMed ID: 2424321
[TBL] [Abstract][Full Text] [Related]
4. In vitro and in vivo effect of proglumide on cholecystokinin-stimulated amylase release in mouse pancreatic acini.
Iwamoto Y; Nakamura R; Akanuma Y
Gastroenterol Jpn; 1984 Feb; 19(1):53-8. PubMed ID: 6202584
[TBL] [Abstract][Full Text] [Related]
5. Structural features of various proglumide-related cholecystokinin receptor antagonists.
Jensen RT; Zhou ZC; Murphy RB; Jones SW; Setnikar I; Rovati LA; Gardner JD
Am J Physiol; 1986 Dec; 251(6 Pt 1):G839-46. PubMed ID: 2431626
[TBL] [Abstract][Full Text] [Related]
6. Loxiglumide. A new proglumide analog with potent cholecystokinin antagonistic activity in the rat pancreas.
Otsuki M; Fujii M; Nakamura T; Okabayashi Y; Tani S; Fujisawa T; Koide M; Baba S
Dig Dis Sci; 1989 Jun; 34(6):857-64. PubMed ID: 2470557
[TBL] [Abstract][Full Text] [Related]
7. Effects of a new proglumide analogue CR 1392 on pancreatic exocrine secretion in the rat.
Otsuki M; Fujii M; Nakamura T; Okabayashi Y; Tani S; Fujisawa T; Koide M; Baba S
Digestion; 1989; 42(2):61-9. PubMed ID: 2475379
[TBL] [Abstract][Full Text] [Related]
8. Proglumide analogues: potent cholecystokinin receptor antagonists.
Jensen RT; Murphy RB; Trampota M; Schneider LH; Jones SW; Howard JM; Gardner JD
Am J Physiol; 1985 Aug; 249(2 Pt 1):G214-20. PubMed ID: 2411147
[TBL] [Abstract][Full Text] [Related]
9. CR-1409: a potent inhibitor of cholecystokinin-stimulated amylase release and cholecystokinin binding in rat pancreatic acini.
Iwamoto Y; Yamamoto R; Kuzuya T
Pancreas; 1987; 2(1):85-90. PubMed ID: 2437574
[TBL] [Abstract][Full Text] [Related]
10. Effects of three different cholecystokinin receptor antagonists on basal and stimulated insulin and glucagon secretion in mice.
Karlsson S; Ahrén B
Acta Physiol Scand; 1989 Mar; 135(3):271-8. PubMed ID: 2648765
[TBL] [Abstract][Full Text] [Related]
11. Proglumide analogues CR 1409 and CR 1392 inhibit cholecystokinin-stimulated insulin release more potently than exocrine secretion from the isolated perfused rat pancreas.
Okabayashi Y; Otsuki M; Nakamura T; Fujii M; Tani S; Fujisawa T; Koide M; Hasegawa H; Baba S
Pancreas; 1990 May; 5(3):291-7. PubMed ID: 2188254
[TBL] [Abstract][Full Text] [Related]
12. [Inhibitory effect of a new proglumide derivative, loxiglumide, on CCK action in isolated rat pancreatic acini].
Fujii M; Otsuki M; Nakamura T; Okabayashi Y; Tani S; Fujisawa T; Koide M; Baba S
Nihon Shokakibyo Gakkai Zasshi; 1989 Jan; 86(1):77-82. PubMed ID: 2471851
[TBL] [Abstract][Full Text] [Related]
13. Proglumide and benzotript: members of a different class of cholecystokinin receptor antagonists.
Hahne WF; Jensen RT; Lemp GF; Gardner JD
Proc Natl Acad Sci U S A; 1981 Oct; 78(10):6304-8. PubMed ID: 6171817
[TBL] [Abstract][Full Text] [Related]
14. Effects of proglumide on ductal and basolateral secretion of pancreatic digestive enzymes.
Niederau C; Grendell JH; Rothman SS
Am J Physiol; 1985 Jul; 249(1 Pt 1):G100-7. PubMed ID: 2409815
[TBL] [Abstract][Full Text] [Related]
15. Effects of proglumide on cholecystokinin-8-induced exocrine and endocrine pancreatic responses in conscious sheep.
Mineo H; Iwaki N; Kogishi K; Onaga T; Kato S; Zabielski R
Comp Biochem Physiol A Physiol; 1997 Nov; 118(3):759-64. PubMed ID: 9406447
[TBL] [Abstract][Full Text] [Related]
16. Asperlicin: a unique nonpeptide cholecystokinin antagonist.
Zucker KA; Adrian TE; Zdon MJ; Ballantyne GH; Modlin IM
Surgery; 1987 Aug; 102(2):163-70. PubMed ID: 2441481
[TBL] [Abstract][Full Text] [Related]
17. Characterization of a new CCK antagonist, L364,718: in vitro and in vivo studies.
Louie DS; Liang JP; Owyang C
Am J Physiol; 1988 Sep; 255(3 Pt 1):G261-6. PubMed ID: 2458681
[TBL] [Abstract][Full Text] [Related]
18. Relationship of cholecystokinin receptor binding to regulation of biological functions in pancreatic acini.
Sankaran H; Goldfine ID; Bailey A; Licko V; Williams JA
Am J Physiol; 1982 Mar; 242(3):G250-7. PubMed ID: 6175228
[TBL] [Abstract][Full Text] [Related]
19. Effects of proglumide on pancreatic endocrine and exocrine function in healthy humans.
Funakoshi A; Nakano I; Shinozaki H; Miyazaki K; Ibayashi H
Regul Pept; 1987 Jun; 17(6):311-8. PubMed ID: 3299507
[TBL] [Abstract][Full Text] [Related]
20. Lorglumide and loxiglumide inhibit gastrin-stimulated DNA synthesis in a rat tumoral acinar pancreatic cell line (AR42J).
Seva C; Scemama JL; Bastié MJ; Pradayrol L; Vaysse N
Cancer Res; 1990 Sep; 50(18):5829-33. PubMed ID: 2393852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
